Supplementation of conventional therapy with the novel grain Salba (Salvia hispanica L.) improves major and emerging cardiovascular risk factors in type 2 diabetes: results of a randomized controlled trial
- PMID: 17686832
- DOI: 10.2337/dc07-1144
Supplementation of conventional therapy with the novel grain Salba (Salvia hispanica L.) improves major and emerging cardiovascular risk factors in type 2 diabetes: results of a randomized controlled trial
Abstract
Objective: To determine whether addition of Salba (Salvia hispanica L.), a novel whole grain that is rich in fiber, alpha-linolenic acid (ALA), and minerals to conventional treatment is associated with improvement in major and emerging cardiovascular risk factors in individuals with type 2 diabetes.
Research design and methods: Using a single-blind cross-over design, subjects were randomly assigned to receive either 37 +/- 4 g/day of Salba or wheat bran for 12 weeks while maintaining their conventional diabetes therapies. Twenty well-controlled subjects with type 2 diabetes (11 men and 9 women, aged 64 +/- 8 years, BMI 28 +/- 4 kg/m2, and A1C 6.8 +/- 0.9%) completed the study. This study was set in the outpatient clinic of the Risk Factor Modification Center, St. Michael's Hospital, Toronto, Canada.
Results: Compared with the control treatment, Salba reduced systolic blood pressure (SBP) by 6.3 +/- 4 mmHg (P < 0.001), high-sensitivity C-reactive protein (hs-CRP) (mg/l) by 40 +/- 1.6% (P = 0.04), and vonWillebrand factor (vWF) by 21 +/- 0.3% (P = 0.03), with significant decreases in A1C and fibrinogen in relation to the Salba baseline but not with the control treatment. There were no changes in safety parameters including liver, kidney and hemostatic function, or body weight. Both plasma ALA and eicosapentaenoic polyunsaturated fatty acid levels were increased twofold (P < 0.05) while consuming Salba.
Conclusions: Long-term supplementation with Salba attenuated a major cardiovascular risk factor (SBP) and emerging factors (hs-CRP and vWF) safely beyond conventional therapy, while maintaining good glycemic and lipid control in people with well-controlled type 2 diabetes.
Trial registration: ClinicalTrials.gov NCT00362011.
Similar articles
-
Reduction in postprandial glucose excursion and prolongation of satiety: possible explanation of the long-term effects of whole grain Salba (Salvia Hispanica L.).Eur J Clin Nutr. 2010 Apr;64(4):436-8. doi: 10.1038/ejcn.2009.159. Epub 2010 Jan 20. Eur J Clin Nutr. 2010. PMID: 20087375 Clinical Trial.
-
Chia seed does not promote weight loss or alter disease risk factors in overweight adults.Nutr Res. 2009 Jun;29(6):414-8. doi: 10.1016/j.nutres.2009.05.011. Nutr Res. 2009. PMID: 19628108 Clinical Trial.
-
A controlled study of consumption of beta-glucan-enriched soups for 2 months by type 2 diabetic free-living subjects.Br J Nutr. 2010 Feb;103(3):422-8. doi: 10.1017/S0007114509991875. Epub 2009 Sep 28. Br J Nutr. 2010. PMID: 19781120 Clinical Trial.
-
Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy.Clin Ther. 2007 Jun;29(6 Pt 1):1236-53. doi: 10.1016/j.clinthera.2007.07.005. Clin Ther. 2007. PMID: 18036387 Review.
-
Glycemic control and cardiovascular diseases in Type 2 diabetes mellitus. Beyond fasting glycemia and glycosylated hemoglobin.Diabetes Nutr Metab. 2000 Aug;13(4):182-5. Diabetes Nutr Metab. 2000. PMID: 10961484 Review. No abstract available.
Cited by 15 articles
-
The Chemical Composition and Nutritional Value of Chia Seeds-Current State of Knowledge.Nutrients. 2019 May 31;11(6):1242. doi: 10.3390/nu11061242. Nutrients. 2019. PMID: 31159190 Free PMC article. Review.
-
Salvia hispanica L. (chia) seeds oil extracts reduce lipid accumulation and produce stress resistance in Caenorhabditis elegans.Nutr Metab (Lond). 2018 Nov 26;15:83. doi: 10.1186/s12986-018-0317-4. eCollection 2018. Nutr Metab (Lond). 2018. PMID: 30505336 Free PMC article.
-
Chia Seed Does Not Improve Cognitive Impairment in SAMP8 Mice Fed with High Fat Diet.Nutrients. 2018 Aug 14;10(8):1084. doi: 10.3390/nu10081084. Nutrients. 2018. PMID: 30110883 Free PMC article.
-
Medicinal Plants with Multiple Effects on Diabetes Mellitus and Its Complications: a Systematic Review.Curr Diab Rep. 2018 Aug 13;18(10):72. doi: 10.1007/s11892-018-1042-0. Curr Diab Rep. 2018. PMID: 30105479
-
Unravelling the secret of seed-based gels in water: the nanoscale 3D network formation.Sci Rep. 2018 May 9;8(1):7315. doi: 10.1038/s41598-018-25691-3. Sci Rep. 2018. PMID: 29743527 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
-
Full Text Sources
-
Other Literature Sources
-
Medical
-
Miscellaneous